Biostar Pharmaceuticals Inc  

(Public, NASDAQ:BSPM)   Watch this stock  
Find more results for BSPM
4.06
+0.07 (1.75%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.87 - 4.60
52 week 1.08 - 6.65
Open 3.96
Vol / Avg. 508,529.00/1.65M
Mkt cap 9.13M
P/E     -
Div/yield     -
EPS -11.57
Shares 2.21M
Beta 2.26
Inst. own 5%
Aug 17, 2016
Q2 2016 Biostar Pharmaceuticals Inc Earnings Release (Estimated) Add to calendar
May 23, 2016
Q1 2016 Biostar Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -77.38% -92.57%
Operating margin -83.40% -87.57%
EBITD margin - -64.13%
Return on average assets -4.89% -37.87%
Return on average equity -5.64% -43.07%
Employees 438 -
CDP Score - -

Address

NO. 588 Shijixi Avenue
XIANYANG, 712046
China
+86-29-33686638 (Phone)
+86-29-33685386 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The Company's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Officers and directors

Ronghua Wang Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Qinghua Liu Interim Chief Financial Officer, Director
Age: 47
Bio & Compensation  - Reuters
Zhenghong Wang Chief Operating Officer
Age: 34
Bio & Compensation  - Reuters
Shuang Gong Secretary of Board
Age: 47
Bio & Compensation  - Reuters
Leung King-Fai Independent Director
Age: 41
Bio & Compensation  - Reuters
Zhongyang Shang Independent Director
Age: 63
Bio & Compensation  - Reuters
Haipeng Wu Independent Director
Age: 57
Bio & Compensation  - Reuters